ESR2 and hydrops fetalis: All these findings thus suggest that ERβ could serve as a potential therapeutic target against HF, which is further supported by studies investigating ERα and ERβ agonists, in which ERβ was found to be the main receptor for E2 being able to rescue cardiac functioning in HF [30].